These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33242523)

  • 21. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
    Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
    Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
    Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and Immunogenicity of Virus-Like Particles of Feline Parvovirus from the Tiger.
    Jiao C; Zhang H; Liu W; Jin H; Liu D; Zhao J; Feng N; Zhang C; Shi J
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32188011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
    Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
    Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of parvovirus-like particles for vaccination and induction of multiple immune responses.
    Casal JI
    Biotechnol Appl Biochem; 1999 Apr; 29(2):141-50. PubMed ID: 10075910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae.
    Lou S; Xu B; Huang Q; Zhi N; Cheng F; Wong S; Brown K; Delwart E; Liu Z; Qiu J
    Virology; 2012 Jan; 422(1):59-69. PubMed ID: 22044541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan.
    Chen MY; Yang SJ; Hung CC
    Emerg Infect Dis; 2011 Oct; 17(10):1954-6. PubMed ID: 22000381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Breast Cancer-Related Epitopes Targeting the IGF-1 Receptor in Chimeric Human Parvovirus B19 Virus-Like Particles.
    Salazar-González JA; Ruiz-Cruz AA; Bustos-Jaimes I; Moreno-Fierros L
    Mol Biotechnol; 2019 Oct; 61(10):742-753. PubMed ID: 31317318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by
    Shao S; Wang Q; Jin Y; Zhang X; Liu Z; Chen S; Wu H; Yang S; Tang F; Su J; Liang Y; Zhang J; Li Q
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
    Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
    J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
    Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
    BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses.
    Sedlik C; Dridi A; Deriaud E; Saron MF; Rueda P; Sarraseca J; Casal JI; Leclerc C
    J Virol; 1999 Apr; 73(4):2739-44. PubMed ID: 10074120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles.
    Li T; Lin H; Zhang Y; Li M; Wang D; Che Y; Zhu Y; Li S; Zhang J; Ge S; Zhao Q; Xia N
    Vaccine; 2014 Apr; 32(17):1921-31. PubMed ID: 24530406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation.
    Fryer JF; Delwart E; Bernardin F; Tuke PW; Lukashov VV; Baylis SA
    J Gen Virol; 2007 Aug; 88(Pt 8):2162-2167. PubMed ID: 17622618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
    Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
    J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability and integrity of self-assembled bovine parvovirus virus‑like particles (BPV‑VLPs) of VP2 and combination of VP1VP2 assisted by baculovirus-insect cell expression: a potential logistical platform for vaccine deployment.
    Wubshet AK; Li GX; Li Q; Dai JF; Ding YZ; Zhou L; Qu M; Wang Y; Ma Z; Werid GM; Abera BH; Kebede AT; Sun Y; Yin X; Liu Y; Jie Z
    Virol J; 2024 Apr; 21(1):87. PubMed ID: 38641833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.